Animalcare Group Plc Net Assets
Animalcare Group Plc net assets. Based on the latest financial reports, Animalcare Group Plc (ANCR) has net assets worth GBX114.54 Million GBX (≈ $13.94K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX158.10 Million ≈ $19.24K USD) and total liabilities (GBX43.56 Million ≈ $5.30K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore ANCR net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX114.54 Million |
| % of Total Assets | 72.45% |
| Annual Growth Rate | 17.24% |
| 5-Year Change | 45.36% |
| 10-Year Change | 380.35% |
| Growth Volatility | 57.93 |
Net Assets of Animalcare Group Plc (2000–2025)
Net assets of Animalcare Group Plc from 2000 to 2025. This chart illustrates how Animalcare Group Plc's net assets have evolved over time, based on quarterly financial data. See ANCR net asset quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Animalcare Group Plc (2000–2025)
The table below shows the annual net assets of Animalcare Group Plc from 2000 to 2025. For live market cap and overall valuation, see ANCR market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | GBX114.54 Million ≈ $13.94K |
+1.08% |
| 2024-12-31 | GBX113.31 Million ≈ $13.79K |
+45.47% |
| 2023-12-31 | GBX77.89 Million ≈ $9.48K |
-1.38% |
| 2022-12-31 | GBX78.99 Million ≈ $9.61K |
+0.24% |
| 2021-12-31 | GBX78.80 Million ≈ $9.59K |
-3.42% |
| 2020-12-31 | GBX81.59 Million ≈ $9.93K |
-0.36% |
| 2019-12-31 | GBX81.89 Million ≈ $9.96K |
-5.43% |
| 2018-12-31 | GBX86.59 Million ≈ $10.54K |
-3.40% |
| 2017-12-31 | GBX89.64 Million ≈ $10.91K |
+275.94% |
| 2017-06-30 | GBX23.84 Million ≈ $2.90K |
+5.91% |
| 2016-06-30 | GBX22.52 Million ≈ $2.74K |
+7.26% |
| 2015-06-30 | GBX20.99 Million ≈ $2.55K |
+7.91% |
| 2014-06-30 | GBX19.45 Million ≈ $2.37K |
+8.30% |
| 2013-06-30 | GBX17.96 Million ≈ $2.19K |
+6.68% |
| 2012-06-30 | GBX16.84 Million ≈ $2.05K |
+6.64% |
| 2011-06-30 | GBX15.79 Million ≈ $1.92K |
+12.13% |
| 2010-06-30 | GBX14.08 Million ≈ $1.71K |
-8.46% |
| 2009-06-30 | GBX15.38 Million ≈ $1.87K |
+5.03% |
| 2008-06-30 | GBX14.64 Million ≈ $1.78K |
+138.63% |
| 2007-06-30 | GBX6.14 Million ≈ $746.70 |
+5.48% |
| 2006-06-30 | GBX5.82 Million ≈ $707.88 |
+2.34% |
| 2005-06-30 | GBX5.68 Million ≈ $691.70 |
+20.52% |
| 2004-06-30 | GBX4.72 Million ≈ $573.92 |
+8.36% |
| 2003-06-30 | GBX4.35 Million ≈ $529.63 |
+14.61% |
| 2002-06-30 | GBX3.80 Million ≈ $462.11 |
+56.43% |
| 2001-06-30 | GBX2.43 Million ≈ $295.42 |
+22.32% |
| 2000-06-30 | GBX1.99 Million ≈ $241.52 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Animalcare Group Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4378.9% over the analyzed period, potentially due to dividend distributions or operating losses.
Animalcare Group Plc Net Assets Breakdown (December 2025)
Animalcare Group Plc net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX13.81 Million | 12.06% |
| Other Comprehensive Income | GBX1.92 Million | 1.67% |
| Other Components | GBX149.99 Million | 130.95% |
| Total Equity | GBX114.54 Million | 100.00% |
Animalcare Group Plc Competitors by Market Cap
The table below lists competitors of Animalcare Group Plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Montanaro European Smaller Companies Trust plc
LSE:MTE
|
$2.82 Million |
|
Canasil Resources Inc.
V:CLZ
|
$2.82 Million |
|
AH-Vest Limited
JSE:AHL
|
$2.82 Million |
|
Benjamin Hornigold Ltd
AU:BHD
|
$2.82 Million |
|
ICZOOM Group Inc. Class A Ordinary Shares
NASDAQ:IZM
|
$2.81 Million |
|
Ordissimo
PA:ALORD
|
$2.81 Million |
|
Goenka Diamond and Jewels Limited
NSE:GOENKA
|
$2.81 Million |
|
GSS Infotech Limited
NSE:GSS
|
$2.81 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Animalcare Group Plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 113,312,000 to 114,540,000, a change of 1,228,000 (1.1%).
- Net income of 5,078,000 contributed positively to equity growth.
- Dividend payments of 3,587,000 reduced retained earnings.
- New share issuances of 14,000 increased equity.
- Other comprehensive income decreased equity by 174,999.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX5.08 Million | +4.43% |
| Dividends Paid | GBX3.59 Million | -3.13% |
| Share Issuances | GBX14.00K | +0.01% |
| Other Comprehensive Income | GBX-175.00K | -0.15% |
| Other Changes | GBX-102.00K | -0.09% |
| Total Change | GBX- | 1.08% |
Book Value vs Market Value Analysis
This analysis compares Animalcare Group Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 203.12x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 3541.05x to 203.12x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-06-30 | GBX0.09 | GBX335.00 | x |
| 2006-06-30 | GBX0.10 | GBX335.00 | x |
| 2007-06-30 | GBX0.10 | GBX335.00 | x |
| 2008-06-30 | GBX0.24 | GBX335.00 | x |
| 2009-06-30 | GBX0.26 | GBX335.00 | x |
| 2010-06-30 | GBX0.23 | GBX335.00 | x |
| 2011-06-30 | GBX0.26 | GBX335.00 | x |
| 2012-06-30 | GBX0.28 | GBX335.00 | x |
| 2013-06-30 | GBX0.30 | GBX335.00 | x |
| 2014-06-30 | GBX0.32 | GBX335.00 | x |
| 2015-06-30 | GBX0.35 | GBX335.00 | x |
| 2016-06-30 | GBX0.37 | GBX335.00 | x |
| 2017-06-30 | GBX0.40 | GBX335.00 | x |
| 2017-12-31 | GBX1.49 | GBX335.00 | x |
| 2018-12-31 | GBX1.44 | GBX335.00 | x |
| 2019-12-31 | GBX1.36 | GBX335.00 | x |
| 2020-12-31 | GBX1.36 | GBX335.00 | x |
| 2021-12-31 | GBX1.31 | GBX335.00 | x |
| 2022-12-31 | GBX1.30 | GBX335.00 | x |
| 2023-12-31 | GBX1.28 | GBX335.00 | x |
| 2024-12-31 | GBX1.83 | GBX335.00 | x |
| 2025-12-31 | GBX1.65 | GBX335.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Animalcare Group Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.43%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.70%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 1.38x
- Recent ROE (4.43%) is below the historical average (6.09%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 4.93% | 3.71% | 1.12x | 1.18x | GBX-288.50K |
| 2006 | 3.49% | 2.59% | 1.01x | 1.34x | GBX-378.80K |
| 2007 | 4.07% | 3.01% | 1.10x | 1.23x | GBX-363.70K |
| 2008 | 6.10% | 7.60% | 0.47x | 1.70x | GBX-571.50K |
| 2009 | 6.75% | 5.89% | 0.70x | 1.65x | GBX-499.20K |
| 2010 | -7.32% | -9.19% | 0.49x | 1.64x | GBX-2.44 Million |
| 2011 | 14.73% | 19.66% | 0.63x | 1.19x | GBX746.10K |
| 2012 | 10.27% | 15.93% | 0.56x | 1.16x | GBX45.30K |
| 2013 | 10.49% | 15.56% | 0.56x | 1.20x | GBX88.80K |
| 2014 | 10.99% | 16.59% | 0.57x | 1.16x | GBX191.70K |
| 2015 | 12.07% | 18.72% | 0.55x | 1.17x | GBX434.90K |
| 2016 | 11.70% | 17.92% | 0.55x | 1.19x | GBX382.50K |
| 2017 | 10.36% | 15.57% | 0.55x | 1.21x | GBX85.50K |
| 2017 | 0.21% | 0.30% | 0.41x | 1.69x | GBX-8.78 Million |
| 2018 | -0.26% | -0.31% | 0.50x | 1.66x | GBX-8.88 Million |
| 2019 | -1.63% | -1.88% | 0.55x | 1.57x | GBX-9.53 Million |
| 2020 | 0.29% | 0.33% | 0.57x | 1.53x | GBX-7.93 Million |
| 2021 | -0.10% | -0.10% | 0.67x | 1.40x | GBX-7.96 Million |
| 2022 | 2.49% | 2.74% | 0.61x | 1.50x | GBX-5.93 Million |
| 2023 | 1.54% | 1.61% | 0.70x | 1.37x | GBX-6.59 Million |
| 2024 | 28.43% | 43.40% | 0.47x | 1.40x | GBX20.89 Million |
| 2025 | 4.43% | 5.70% | 0.56x | 1.38x | GBX-6.38 Million |
Industry Comparison
This section compares Animalcare Group Plc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $3,246,133,179
- Average return on equity (ROE) among peers: -1.84%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Animalcare Group Plc (ANCR) | GBX114.54 Million | 4.93% | 0.38x | $2.81 Million |
| Allergy Therapeutics (AGY) | $48.53 Million | 5.95% | 0.81x | $982.37K |
| Alliance Pharma plc (APH) | $6.67 Million | -48.15% | 5.96x | $4.26 Million |
| Celadon Pharmaceuticals PLC (CEL) | $6.41 Million | -74.61% | 0.03x | $112.25K |
| Chill Brands Group PLC (CHLL) | $-1.23 Million | 0.00% | 0.00x | $101.80K |
| Eco Animal Health Group Plc (EAH) | $98.17 Million | 10.76% | 0.16x | $681.55K |
| HUTCHMED China Ltd (HCM) | $83.65 Million | 4.35% | 1.50x | $21.47 Million |
| Hikma Pharmaceuticals PLC (HIK) | $1.35 Billion | 18.64% | 0.92x | $44.46 Million |
| Haleon PLC (HLN) | $27.41 Billion | 2.39% | 0.30x | $367.23 Million |
| Indivior PLC (INDV) | $209.00 Million | 64.11% | 6.90x | $18.79 Million |
About Animalcare Group Plc
Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally. It operates through Animalcare Europe and Randlab segments. The company offers Orozyme, an enzymatic toothpaste for dental care in cats and dogs; Danilon, an oral treatment for pain in… Read more